VE

VELTRA Corporation

Global OTA for curated tours & experiences, focusing on travel to and from Japan.

7048 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
中央区日本橋2−13−12
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

VELTRA Corporation is a global online travel agency (OTA) specializing in the booking of tours, activities, and unique local experiences. Since 2004, the company has connected travelers with a vast, curated selection of options, ranging from sightseeing excursions and cultural workshops to admission tickets for attractions. VELTRA's business comprises an OTA platform and a tourism IT segment, serving a global customer base with a strategic focus on both inbound tourism to Japan and outbound travel for the Japanese market. Emphasizing quality and richness, VELTRA aims to provide "genuine experiences" that create lasting memories, distinguishing itself through expert curation and a diverse portfolio of activities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 08:33
Regulatory News Service
確認書
Japanese 8.0 KB
2025-08-14 08:32
Interim Report
半期報告書-第36期(2025/01/01-2025/12/31)
Japanese 177.0 KB
2025-03-27 08:49
Regulatory News Service
臨時報告書
Japanese 26.9 KB
2025-03-27 08:48
Regulatory News Service
確認書
Japanese 8.0 KB
2025-03-27 08:48
Regulatory News Service
内部統制報告書-第35期(2024/01/01-2024/12/31)
Japanese 22.5 KB
2025-03-27 08:47
Annual Report
有価証券報告書-第35期(2024/01/01-2024/12/31)
Japanese 1.3 MB
2025-03-04 09:00
Regulatory News Service
確認書
Japanese 8.1 KB
2025-03-04 09:00
Regulatory News Service
確認書
Japanese 8.1 KB
2025-03-04 08:56
Regulatory News Service
訂正有価証券報告書-第33期(2022/01/01-2022/12/31)
Japanese 503.5 KB
2025-03-04 08:56
Regulatory News Service
訂正有価証券報告書-第34期(2023/01/01-2023/12/31)
Japanese 724.0 KB
2024-08-14 09:41
Regulatory News Service
確認書
Japanese 8.0 KB
2024-08-14 09:40
Interim Report
半期報告書-第35期(2024/01/01-2024/12/31)
Japanese 162.3 KB
2024-05-14 09:35
Report Publication Announcement
確認書
Japanese 8.0 KB
2024-05-14 09:34
Quarterly Report
四半期報告書-第35期第1四半期(2024/01/01-2024/03/31)
Japanese 136.3 KB
2024-03-28 08:50
Post-Annual General Meeting Information
臨時報告書
Japanese 21.4 KB

Automate Your Workflow. Get a real-time feed of all VELTRA Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for VELTRA Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
A holding company driving regional growth by supporting construction, HR, and nursing care businesses.
Japan 7369
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden IMMU
Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America N/A
MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan 9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan 9227
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan 3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan 4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea 417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden MODTX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland MOC

Talk to a Data Expert

Have a question? We'll get back to you promptly.